Cizzle Biotechnology Holdings PLC - Asset Resilience Ratio

Latest as of December 2023: 83.46%

Cizzle Biotechnology Holdings PLC (CIZ) has an Asset Resilience Ratio of 83.46% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Cizzle Biotechnology Holdings PLC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

GBX1.41 Million

≈ $171.92 USD Cash + Short-term Investments

Total Assets

GBX1.69 Million

≈ $205.99 USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2023)

This chart shows how Cizzle Biotechnology Holdings PLC's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Cizzle Biotechnology Holdings PLC to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Cizzle Biotechnology Holdings PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CIZ company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX1.41 Million	83.46%
Total Liquid Assets	GBX1.41 Million	83.46%

Asset Resilience Insights

Very High Liquidity: Cizzle Biotechnology Holdings PLC maintains exceptional liquid asset reserves at 83.46% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cizzle Biotechnology Holdings PLC Industry Peers by Asset Resilience Ratio

Compare Cizzle Biotechnology Holdings PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Hugel Inc KQ:145020	Biotechnology	29.57%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	2.30%
Absci Corp NASDAQ:ABSI	Biotechnology	59.86%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%

Annual Asset Resilience Ratio for Cizzle Biotechnology Holdings PLC (2023–2023)

The table below shows the annual Asset Resilience Ratio data for Cizzle Biotechnology Holdings PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	83.46%	GBX1.41 Million ≈ $171.92	GBX1.69 Million ≈ $205.99	--

pp = percentage points

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$135.04K

GBX1.11 Billion GBX

Market Cap Rank

#31201 Global

#1067 in UK

Share Price

GBX2.80

Change (1 day)

-1.75%

52-Week Range

GBX1.29 - GBX3.65

All Time High

GBX1144.91